Outreach

Judith Guasch participates in the project “YouMaker: así se hace la Ciencia” of ICMAB-CSIC.

Last July, we hosted Emma Catini, a participant from the "Joves i Ciència" programme by Fundació Catalunya La Pedrera. She had the opportunity to collaborate with our students developing biomaterials for oncological applications.

On 24 October 2021, Llorenç Rafecas, founder of the pharmaceutical company Enantia and President of “El Centre”, interviewed ICMAB researcher Judith Guasch in the framework of the “Cicle de Ciència i Futur” organized by “El Centre”; a cultural center of Llorenç del Penedès. Judith explained her personal experience as a researcher and her developments in the field of biomaterials for cancer immunotherapy.

On 11 June 2024, Dr. Tony Anagor, Professor of Communication at IESE (Barcelona) and founder of Emotionally Intelligent Negotiation, interviewed ICMAB researcher Judith Guasch in his podcast “Empathy at the Table”. Judith explained her personal experience as a researcher and her developments in the field of biomaterials for cancer immunotherapy.

Judith Guasch and her group at the Nanomolunit are focusing on the development of hydrogels for the culture of T cells used for cancer immunotherapy through the adoptive cellular therapy. This therapy is based on reinforcing and multiplying T cells of the own body. The idea is to create 3D hydrogel structures that imitate the lymph nodes where T cell proliferate, to grow and modify them and introduce them back to the body.

Last July, we hosted Sara Guitart, a participant from the "Joves i Ciència" programme by Fundació Catalunya La Pedrera. She had the opportunity to collaborate with our PhD students developing biomaterials for oncological applications.